NDC properties for "24 HR Androderm 0.167 MG/HR Transdermal Patch" (RxCUI 1190957)
About this data
The tables show NDC propoerties for 24 HR Androderm 0.167 MG/HR Transdermal Patch with the RxCUI 1190957
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 24 HR Androderm 0.167 MG/HR Transdermal Patch (RxCUI 1190957)
| MMSL_CODE | BD39859 |
|---|---|
| RxCUI | 1190957 |
| Prescribable Synonym | ANDRODERM 4 MG/Day 24HR Transdermal System |
| RXNAV_STR | ANDRODERM 4 MG/Day 24HR Transdermal System |
| RxNorm Name | 24 HR testosterone 0.167 MG/HR Transdermal System [Androderm] |
| RxNorm Synonym | 24 HR Androderm 0.167 MG/HR Transdermal Patch |
| RxNorm Synonym | 24 HR Androderm 0.167 MG/HR Transdermal System |
| RxNorm Synonym | Androderm 4 MG per 24 HR Transdermal Patch |
| RxNorm Synonym | ANDRODERM 4 MG/Day 24HR Transdermal System |
| Related queries | Interactions (for RxCUI 1190957) |
NDC Properties
NDC Item 00023599204
| NDC 9 | 0023-5992 |
|---|---|
| NDC 10 | 0023-5992-04 |
| NDC Item | 00023599204 |
| DCSA | CIII |
| FDA SPL set id | 692017 |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-09-30 |
| Marketing effective time low | 1995-09-29 |
| Marketing status | COMPLETED |
| NDA | NDA020489 |
| Related queries | Properties for NDC 9 0023-5992 |
NDC Item 00023599230
| NDC 9 | 0023-5992 |
|---|---|
| NDC 10 | 0023-5992-30 |
| NDC Item | 00023599230 |
| Packaging | 30 POUCH in 1 CARTON (0023-5992-30) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH |
| DCSA | CIII |
| FDA SPL set id | 692017 |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-09-30 |
| Marketing effective time low | 1995-09-29 |
| Marketing status | COMPLETED |
| NDA | NDA020489 |
| Related queries | Properties for NDC 9 0023-5992 |
NDC Item 00023599204
| NDC 9 | 0023-5992 |
|---|---|
| NDC 10 | 0023-5992-04 |
| NDC Item | 00023599204 |
| DCSA | CIII |
| FDA SPL set id | 692017 |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-09-30 |
| Marketing effective time low | 1995-09-29 |
| Marketing status | COMPLETED |
| NDA | NDA020489 |
| Related queries | Properties for NDC 9 0023-5992 |
NDC Item 00023599230
| NDC 9 | 0023-5992 |
|---|---|
| NDC 10 | 0023-5992-30 |
| NDC Item | 00023599230 |
| Packaging | 30 POUCH in 1 CARTON (0023-5992-30) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH |
| DCSA | CIII |
| FDA SPL set id | 692017 |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-09-30 |
| Marketing effective time low | 1995-09-29 |
| Marketing status | COMPLETED |
| NDA | NDA020489 |
| Related queries | Properties for NDC 9 0023-5992 |